Cargando…
Pharmacovigilance in oncology
Background Side effects of cancer therapy are one of the most important issues faced by cancer patients during their illness. Pharmacovigilance, namely the science and activities aimed at monitoring the safety of drugs, is particularly important in oncology, due to the intrinsic biologic toxicity of...
Autores principales: | Baldo, Paolo, Fornasier, Giulia, Ciolfi, Laura, Sartor, Ivana, Francescon, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132974/ https://www.ncbi.nlm.nih.gov/pubmed/30069667 http://dx.doi.org/10.1007/s11096-018-0706-9 |
Ejemplares similares
-
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016) -
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018) -
An historical overview over Pharmacovigilance
por: Fornasier, Giulia, et al.
Publicado: (2018) -
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018) -
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
por: Fornasier, G., et al.
Publicado: (2018)